LRMR
#3356
Larimar Therapeutics, Inc. - Common Stock
2.5 3 USD
-0.05%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-5.24%
Variación mensual
-34.11%
Variación en los últimos 6 meses
-48.47%
Cambio anual
-39.33%
Cierres anteriores
2.6 7
Open
2.6 6
Mínimo
2.5 3
Máximo
2.6 9
Financials
- Market Capitalization 262.82 M
- Employee 71
- Founded 2005
- CEO N/A
- Website www.larimartx.com
- Headquarter Delaware, United States
- FIGI BBG001J2NVH0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
3.2
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3322 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 4.54 USD | -0.66% | -1.30% | -11.33% | -17.90% | 274.50 M USD | ||
| 3331 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 2.48 USD | -3.13% | -4.98% | -24.62% | -36.73% | 272.24 M USD | ||
| 3358 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 3.26 USD | -1.51% | -9.44% | -33.60% | -71.53% | 261.37 M USD | ||
| 3361 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 17.77 USD | +7.50% | +4.65% | +17.29% | +74.22% | 260.83 M USD |